Home|Journals|Articles by Year Follow on Twitter| Subscribe to List

Directory for Medical Articles
 

Open Access

Original Article

IJMDC. 2019; 3(1): 26-29


Metformin and intravenous contrast when time not help, A retrospective study at King Abdulaziz University Hospital, Jeddah, Saudi Arabia

Dalya Alqarni, Asma Alshehri, Raghad Aldehasi, Lujain Al-Sayegh, Dania Binrahma, Naeem AlShoaibi.

Abstract
Background: Metformin is a common drug used for antihyperglycemic therapy in type 2 diabetes. Additionally, intravenous (IV) contrast may be administered when using the various imaging techniques to enhance the visualization of body structures, and deterioration of renal function and lactic acidosis - contrast-induced nephropathy (CIN) - may occasionally happen. The purpose of this research was to assess the current guideline of withholding metformin therapy in patients undergoing contrast-enhanced procedures in both the emergency and inpatient settings.
Methodology: A retrospective study was conducted for all patients who were on metformin and underwent a contrast-enhanced imaging procedure (requiring IV contrast) between January and June 2016 at King Abdulaziz University Hospital in Jeddah, Saudi Arabia.
Results: This study involved 107 patients on metformin who received a contrast-enhanced imaging procedure. Out of 107 patients, 26 were admitted through the ER. Independent t-tests were performed to compare GFR and creatinine, before and after the procedure in both, ER and ward patients; they all had non-significant associations.
Conclusion:
In this study none of the ER patients stopped their metformin before they were administered IV contrast.

Key words: Metformin, Creatinine, GFR, Contrast, Emergency


Full-text options

Full-text Article




Advertisement
American Journal of Preventive Medicine and Public Health

SUBMIT YOUR ARTICLE NOW




ScopeMed.com
BiblioMed Home
Follow ScopeMed on Twitter
Author Tools
eJPort Journal Hosting
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (https://creativecommons.org/licenses/by-nc-sa/4.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
ScopeMed is a Database Service for Scientific Publications. Copyright ScopeMed Information Services.